Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 7, 2017; 23(41): 7415-7424
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7415
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7415
Table 5 Complications and adverse events after postoperative adjuvant transcatheter arterial chemoembolization n (%)
| Complication | Events |
| Nausea and vomiting | 46 (29.11) |
| Fever | 35 (22.2) |
| Pain | 49 (31.0) |
| Alopecia | 5 (3.2) |
| Liver failure | 0 (0.0) |
| Bleeding of esophageal venous plexus | 0 (0.0) |
| Gastrointestinal hemorrhage | 0 (0.0) |
| Heart failure | 0 (0.0) |
| Infection | 0 (0.0) |
| Ectopic embolism syndrome | 0 (0.0) |
| Refractory ascites | 0 (0.0) |
| Pulmonary complication | 2 (1.3) |
| Therapy-related death | 0 (0.0) |
- Citation: Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol 2017; 23(41): 7415-7424
- URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7415.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7415